MCID: FNC023
MIFTS: 27

Fanconi Anemia, Complementation Group N malady

Categories: Genetic diseases, Rare diseases, Nephrological diseases, Bone diseases, Skin diseases, Fetal diseases, Blood diseases

Aliases & Classifications for Fanconi Anemia, Complementation Group N

About this section

Aliases & Descriptions for Fanconi Anemia, Complementation Group N:

Name: Fanconi Anemia, Complementation Group N 51 12
Fanconi Anemia Complementation Group N 69 26
 
Fancn 69

Characteristics:

HPO:

63
fanconi anemia, complementation group n:
Inheritance: autosomal recessive inheritance

Classifications:



External Ids:

OMIM51 610832
MedGen36 C1835817
MeSH38 D005199

Summaries for Fanconi Anemia, Complementation Group N

About this section
OMIM:51 Fanconi anemia (FA) is a clinically and genetically heterogeneous disorder that causes genomic instability.... (610832) more...

MalaCards based summary: Fanconi Anemia, Complementation Group N, also known as fanconi anemia complementation group n, is related to fanconi anemia, complementation group a, and has symptoms including microcephaly, epicanthus and hypertelorism. An important gene associated with Fanconi Anemia, Complementation Group N is PALB2 (Partner And Localizer Of BRCA2). Affiliated tissues include bone and bone marrow.

UniProtKB/Swiss-Prot:69 Fanconi anemia complementation group N: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.

Related Diseases for Fanconi Anemia, Complementation Group N

About this section

Diseases in the Fanconi Anemia, Complementation Group T family:

Fanconi Anemia, Complementation Group L Fanconi Anemia, Complementation Group I
Fanconi Anemia, Complementation Group P Fanconi Anemia, Complementation Group Q
fanconi anemia, complementation group n Fanconi Anemia, Complementation Group a
Fanconi Anemia, Complementation Group J Fanconi Anemia, Complementation Group O

Diseases related to Fanconi Anemia, Complementation Group N via text searches within MalaCards or GeneCards Suite gene sharing:

idRelated DiseaseScoreTop Affiliating Genes
1fanconi anemia, complementation group a10.9

Symptoms for Fanconi Anemia, Complementation Group N

About this section


Clinical features from OMIM:

610832

Human phenotypes related to Fanconi Anemia, Complementation Group N:

 63 (show all 13)
id Description HPO Frequency HPO Source Accession
1 microcephaly63 HP:0000252
2 epicanthus63 HP:0000286
3 hypertelorism63 HP:0000316
4 short neck63 HP:0000470
5 cafe-au-lait spot63 HP:0000957
6 ventricular septal defect63 HP:0001629
7 aplastic anemia63 HP:0001915
8 nephroblastoma63 HP:0002667
9 medulloblastoma63 HP:0002885
10 neuroblastoma63 HP:0003006
11 chromosomal breakage induced by crosslinking agents63 HP:0003221
12 postnatal growth retardation63 HP:0008897
13 short thumb63 HP:0009778

Drugs & Therapeutics for Fanconi Anemia, Complementation Group N

About this section

Drugs for Fanconi Anemia, Complementation Group N (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 16)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
PancrelipaseapprovedPhase 293553608-75-6
Synonyms:
1,4-alpha-D- glucan glucanohydrolase
PA
 
Pancreatic alpha-amylase precursor
Pancrelipase (amylase
lipase
protease)
2
GemcitabineapprovedPhase 2197495058-81-460750
Synonyms:
103882-84-4
122111-03-9
2',2'-DiF-dC
2',2'-Difluoro-2'-deoxycytidine
2',2'-Difluorodeoxycytidine
2'-Deoxy-.beta.-D-2',2'-difluorocytidine
2'-Deoxy-2',2'-difluorocytidine
4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one
4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
95058-81-4
AB1004842
AC1L1TUQ
C07650
CCRIS 8984
CHEBI:175901
CHEMBL888
CID60750
Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine
D02368
DB00441
DDFC
DFDC
DFdC
DFdCyd
Folfugem
GEO
Gamcitabine
GemLip
Gemcel
 
Gemcin
Gemcitabin
Gemcitabina
Gemcitabina [INN-Spanish]
Gemcitabine
Gemcitabine (USAN/INN)
Gemcitabine HCl
Gemcitabine hydrochloride
Gemcitabine stereoisomer
Gemcitabinum
Gemcitabinum [INN-Latin]
Gemtro
Gemzar
Gemzar (hydrochloride)
HMS2089P10
HSDB 7567
Inno-D07001
LS-59139
LY 188011
LY-188011
LY188011
NCGC00168784-01
NChemBio.2007.10-comp25
NSC 613327
NSC613327
TL8005979
UNII-B76N6SBZ8R
ZINC18279854
Zefei
gemcitabine
nchembio.573-comp7
nchembio.90-comp2
3
CisplatinapprovedPhase 2269015663-27-184093, 441203, 2767
Synonyms:
(SP-4-1)-diamminedichloridoplatinum
(SP-4-1)-diamminedichloroplatinum
(SP-4-2)-diamminedichloridoplatinum
(SP-4-2)-diamminedichloroplatinum
Abiplatin
Biocisplatinum
Briplatin
CACP
CDDP
CHEBI:35852
CID441203
CPD0-1392
CPDC
CPDD
Carboquone
Cis Pt II
Cis-DDP
Cis-Diaminedichloroplatinum
Cis-Diamminedichloroplatinum
Cismaplat
Cisplatine
Cisplatino
Cisplatinum
Cisplatyl
Citoplationo
DB00515
DDP
DDPT
Diamminedichloroplatinum
 
EU-0100918
Lederplatin
Neoplatin
Peyrone's chloride
Peyrone's salt
Plastin
Platamine
Platiblastin
Platidiam
Platinex
Platinol
Platinol-AQ
Platinoxan
Platinum Ammine Chloride
Platinum Ammonium Chloride
Platinum Diamine Dichloride
Randa
Trans-DDP
Trans-Diaminedichloroplatinum
Trans-Diamminedichloroplatinum
Trans-Dichlorodiammine Platinum
Trans-Platinumdiammine Dichloride
cis-DDP
cis-Diamminedichloroplatinum
cis-Dichlorodiammineplatinum(II)
cis-[PtCl2(NH3)2]
cis-diamminedichloridoplatinum(II)
cis-diamminedichloroplatinum(II)
nchembio773-comp1
trans-diamminedichloridoplatinum(II)
4
SuccinylcholineapprovedPhase 2161306-40-15314
Synonyms:
2,2'-[(1,4-DIOXOBUTANE-1,4-DIYL)BIS(OXY)]BIS(N,N,N-TRIMETHYLETHANAMINIUM)
2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)
2ha2
2ha6
306-40-1
4-04-00-01451 (Beilstein Handbook Reference)
541-19-5 (diiodide)
55-94-7 (dibromide)
71-27-2 (dichloride)
AC1L1K2T
Anectine
BRN 1805311
C07546
C14H30N2O4
CHEBI:45652
CHEMBL703
CID5314
Choline, succinate (2:1) (ester)
Choline, succinate (ester)
DB00202
Diacetylcholine
Dicholine succinate
Ditilin
Ditiline
HMS2090P14
HSDB 3254
InChI=1/C14H30N2O4/c1-15(2,3)9-11-19-13(17)7-8-14(18)20-12-10-16(4,5)6/h7-12H2,1-6H3/q+2
L000926
LS-53328
Listenon
 
Lopac-S-8251
Lopac0_001080
Lysthenon
MolPort-002-964-486
NCGC00015971-01
NCGC00015971-03
NCGC00162336-01
Quelicin
Quelicin Preservative Free
SCK
ST50437287
STK177290
Scoline
Succicuran
Succinic acid, diester with choline
Succinic acid, diester with choline chloride
Succinocholine
Succinoylcholine
Succinyl choline
Succinylbischoline
Succinylcholine
Succinylcholine Chloride
Succinyldicholine
Sucostrin
Suxamethonium
Suxamethonium chloride
UNII-J2R869A8YF
ZINC01530820
succinylcholine
succinyldicholine
trimethyl-[2-[4-oxo-4-(2-trimethylazaniumylethoxy)butanoyl]oxyethyl]azanium diio
trimethyl-[2-[4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl]oxyethyl]azanium
5
VeliparibinvestigationalPhase 295912444-00-911960529
Synonyms:
(2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium
2-((2R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide
 
ABT 888
ABT-888
veliparib
6pancreatinPhase 2935
7Peripheral Nervous System AgentsPhase 222776
8Poly(ADP-ribose) Polymerase InhibitorsPhase 2309
9Neuromuscular Depolarizing AgentsPhase 2135
10Neuromuscular AgentsPhase 21129
11Antimetabolites, AntineoplasticPhase 27171
12AntimetabolitesPhase 211774
13Antiviral AgentsPhase 29732
14Immunosuppressive AgentsPhase 212770
15Anti-Infective AgentsPhase 221402
16Neuromuscular Blocking AgentsPhase 2414

Interventional clinical trials:

idNameStatusNCT IDPhase
1Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerRecruitingNCT01585805Phase 2

Search NIH Clinical Center for Fanconi Anemia, Complementation Group N

Genetic Tests for Fanconi Anemia, Complementation Group N

About this section

Genetic tests related to Fanconi Anemia, Complementation Group N:

id Genetic test Affiliating Genes
1 Fanconi Anemia, Complementation Group N26

Anatomical Context for Fanconi Anemia, Complementation Group N

About this section

MalaCards organs/tissues related to Fanconi Anemia, Complementation Group N:

35
Bone, Bone marrow

Animal Models for Fanconi Anemia, Complementation Group N or affiliated genes

About this section

Publications for Fanconi Anemia, Complementation Group N

About this section

Variations for Fanconi Anemia, Complementation Group N

About this section

Clinvar genetic disease variations for Fanconi Anemia, Complementation Group N:

5 (show all 13)
id Gene Variation Type Significance SNP ID Assembly Location
1PALB2NM_024675.3(PALB2): c.1653T> A (p.Tyr551Ter)SNVPathogenicrs118203997GRCh37Chr 16, 23646214: 23646214
2PALB2PALB2: c.49-?_2586+?deldeletionPathogenicChr na, -1: -1
3PALB2NM_024675.3(PALB2): c.3549C> G (p.Tyr1183Ter)SNVLikely pathogenic, Pathogenic, risk factorrs118203998GRCh37Chr 16, 23614792: 23614792
4PALB2NM_024675.3(PALB2): c.2962C> T (p.Gln988Ter)SNVPathogenic, risk factorrs118203999GRCh37Chr 16, 23634324: 23634324
5PALB2NM_024675.3(PALB2): c.-200-?_3113+?deldeletionPathogenicChr na, -1: -1
6PALB2NM_024675.3(PALB2): c.1676_1677delAAinsG (p.Gln559Argfs)indelPathogenicrs515726073GRCh38Chr 16, 23634869: 23634870
7PALB2NM_024675.3(PALB2): c.2393_2394insCT (p.Thr799Leufs)insertionPathogenicrs180177113GRCh38Chr 16, 23629760: 23629761
8PALB2NM_024675.3(PALB2): c.2521delA (p.Thr841Glnfs)deletionPathogenicrs180177116GRCh38Chr 16, 23629269: 23629269
9PALB2NM_024675.3(PALB2): c.3116delA (p.Asn1039Ilefs)deletionLikely pathogenic, Pathogenic, risk factorrs180177133GRCh38Chr 16, 23614089: 23614089
10PALB2NM_024675.3(PALB2): c.3323delA (p.Tyr1108Serfs)deletionPathogenicrs180177135GRCh38Chr 16, 23607891: 23607891
11PALB2NM_024675.3(PALB2): c.3350+4A> GSNVPathogenicrs180177136GRCh38Chr 16, 23607860: 23607860
12PALB2NM_024675.3(PALB2): c.395delT (p.Val132Alafs)deletionPathogenicrs180177085GRCh38Chr 16, 23636151: 23636151
13PALB2NM_024675.3(PALB2): c.757_758delCT (p.Leu253Ilefs)deletionPathogenicrs180177092GRCh38Chr 16, 23635788: 23635789

Expression for genes affiliated with Fanconi Anemia, Complementation Group N

About this section
Search GEO for disease gene expression data for Fanconi Anemia, Complementation Group N.

Pathways for genes affiliated with Fanconi Anemia, Complementation Group N

About this section

GO Terms for genes affiliated with Fanconi Anemia, Complementation Group N

About this section

Sources for Fanconi Anemia, Complementation Group N

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet